Stock DXCM DEXCOM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News DexCom, Inc.

Equities

DXCM

US2521311074

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
115.8 USD +0.42% Intraday chart for DexCom, Inc. -2.51% -6.69%
Jun. 05 Transcript : DexCom, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 03:20 PM
Jun. 05 Dexcom, Inc. Announces the Dexcom G7 Continuous Glucose Monitoring System Now Connects Directly to Apple Watch in the United States CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
DexCom : William Blair 44th Annual Growth Stock Conference
PU
Transcript : DexCom, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 03:20 PM
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
BU
Dexcom, Inc. Announces the Dexcom G7 Continuous Glucose Monitoring System Now Connects Directly to Apple Watch in the United States
CI
Dexcom Wins Access to Dexcom One for 100,000 People Living with Type 2 Diabetes
CI
Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes
BU
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
BU
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
CI
Redburn Atlantic Initiates DexCom With Neutral Rating, $130 Price Target
MT
Dexcom Announces Upcoming Conference Presentation
BU
Declaration of Voting Results by DexCom, Inc
CI
Declaration of Voting Results by DexCom, Inc
CI
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
BU
Bio Conscious Announces Strategic Api Integration with Dexcom That Will Elevate the Current Level of Care for Diabetes Patients in Clinical Settings
CI
DexCom : Human Rights Statement
PU
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology
CI
Wall Street: the worst week of 2024 is followed by the best
CF
Morgan Stanley Adjusts DexCom's Price Target to $132 From $122
MT
Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144
MT
Raymond James Adjusts DexCom Price Target to $160 From $151
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DXCM Stock
  4. News DexCom, Inc.